Status:
COMPLETED
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
Lead Sponsor:
University of Jena
Conditions:
Age Related Maculopathy
Eligibility:
All Genders
50-95 years
Phase:
NA
Brief Summary
The primary objective of LUTEGA is it to determine the long term effect (about 1 year) of the supplementation with a fixed combination of lutein/zeaxanthin and omega-3- fatty acids on the optical dens...
Eligibility Criteria
Inclusion
- All non- exudative forms of age related maculopathy
Exclusion
- Exudative age related maculopathy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00763659
Start Date
May 1 2008
End Date
September 1 2011
Last Update
July 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, University Hospital
Jena, Germany, 07743